You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 2, February 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Seizure control with clomiphene therapy. A case report

A. G. Herzog
Neuroendocrine Section, Charles A. Dana Research Institute, Beth Israel Hospital, Boston, MA 02215.

Clinical seizures ceased during six months of clomiphene citrate therapy in a 36-year-old man who had hypogonadotropic hypogonadism, reproductive dysfunction, and a 16-year history of regular seizures. Seizures recurred during the month that followed the discontinuation of clomiphene therapy. This apparent antiseizure effect of clomiphene is discussed in terms of three possible mechanisms of action: (1) Clomiphene may benefit seizures by raising serum levels of antiseizure medications. (2) Clomiphene may improve seizures by normalizing serum testosterone levels. (3) Clomiphene may act at a cerebral level to lessen seizures. A controlled investigation of the effects of clomiphene on epilepsy in the setting of reproductive dysfunction is suggested.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part III: Case Reports
Herzog
Psychosomatics 1999;40:109-116.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.